Author Archives: "Elizabeth Porco"

Elizabeth Porco

Genzyme recognizes sixth annual World MS Day
Genzyme Recognizes Sixth Annual World MS Day - Company Supporting Wide Range of Programs to Help Improve the Lives of People Living with [...]
CHMP adopts positive opinion for PLEGRIDY as a treatment for multiple sclerosis in the EU
CHMP Adopts Positive Opinion for PLEGRIDY™ (Peginterferon Beta-1a) as a Treatment for Multiple Sclerosis in the European Union Friday, [...]
Stem cell update presented at multiple sclerosis conference for healthcare professionals
Stem Cell Update Presented at MS Conference for Healthcare Professionals Cooperative Meeting of CMSC & ACTRIMS, May 28-31, 2014, [...]
Opexa reaches enrollment target in phase IIb trial of personalizedimmunotherapy for SPMS
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple [...]
Teva announces COPAXONE recognized as “Brand of the Year” by Pharm Exec Magazine
Teva announces COPAXONE® recognized as Brand of the Year by Pharmaceutical Executive Magazine JERUSALEM--(BUSINESS WIRE)--May 8, [...]
Leading multiple sclerosis conference offers continuing education credit for pharmacists
Leading Multiple Sclerosis Conference Offers Continuing Education Credit For Pharmacists The Cooperative Meeting of CMSC & ACTRIMS [...]
New TYSABRI analysis shows improved walking speed in significant number of multiple sclerosis patients
New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients Thursday, May 1, 2014 [...]
New data reinforce efficacy of TECFIDERA in multiple sclerosis patients with high disease activity
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease Activity Wednesday, April 30, 2014 7:30 [...]
A farewell tribute to Mike Robinson – President, National Multiple Sclerosis Society of Zimbabwe
A Farewell Tribute to Mike Robinson – President, Multiple Sclerosis Society of Zimbabwe   POET AND SALUTATION DEDICATION: MR. [...]
Slowing of brain atrophy sustained at three years in patients treated with Lemtrada
Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last